Topic overview

Start with the big picture

Culturally endorsed species can provide focused starting points for discovery, while historical remedies have yielded lead compounds such as artemisinin, paclitaxel, and galantamine. Researchers can investigate traditional-use observations through reverse pharmacology, bioassay-guided fractionation, and omics profiling to identify and characterize active constituents. Traditional formulas also offer questions about multi-target effects, and known phytochemicals may be explored for additional indications. These approaches do not replace rigorous evaluation: preliminary safety signals from long-standing use are not a substitute for clinical trials. The broader development pathway also involves standardizing botanical materials, ensuring sustainable sourcing, navigating regulatory frameworks, and addressing intellectual property and benefit-sharing with knowledge-holding communities.